泰德医药（浙江）股份有限公司（03880）于2026年4月8日披露了2026年3月股份变动月报表。报告期为2026年3月1日至3月31日。
报告期内，公司已发行股本由73,598,888股增加至141,800,000股，增幅主要源于将68,201,112股非上市股份转换为H股。相应地，截至本月末，非上市股份数量降至0股，公司注册股本总额为人民币141,800,000元。
无数据显示公司本月有股份购回、注销或库藏股的活动，也未披露与期权或激励计划相关的变动事项。公告显示，公司确认已遵守香港联交所《上市规则》和其他适用的法律法规。
据公开信息，本份月报表由联席公司秘书吴东澄签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.